| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |